(R)-(2-Methyloxiran-2-yl)methyl 4-nitrobenzoate, 95%, 5g

3-Cyanobenzyl bromide, 98.0%, 1g

2-Chloro-4-methylnicotinamide, 95.0%, 250mg

(R)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)(methyl)amino)-3-(tert-butoxy)propanoic acid, 95.0%, 100mg

Syringe filters ROTILABO® PVDF, 0,22 µm, 13 mm, 100 Piece(s)

4-sec-Butylcyclohexylamine (cis- and trans- mixture)>98.0%(GC)(T)5mL

2-Bromo-1-(5-chloro-thiophen-2-yl)-ethanone, 99.0%, 25g

tert-Butyl N-{[1-(bromomethyl)cyclopropyl]methyl}carbamate, 98%, 100mg

2,8-Dimethylimidazo[1,2-a]pyridine-3-carboxylic acid, 95.0%, 250mg

3,3-Dimethylcyclopentanone, 95.0%, 100g

Phenethyl p-Toluenesulfonate>98.0%(T)25g

N-[1-[(3,4-Dimethylphenyl)amino]-2-(4-methylphenyl)-2-oxoethyl]-2-furancarboxamide, 10mg

2-(Aminomethyl)pyrimidine, 95.0%, 1g